Quipt Home Medical Corp.
4.40%
1,930,527
1540013
74880P104
May 19, 2025
May 28, 2025, 04:37 PM
Reporting Persons (4)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | Investment Adviser | 4.40% | 1,928,225 | 0 | 1,928,225 |
| Kanen David | Individual | 4.40% | 1,930,527 | 2,302 | 1,928,225 |
| Philotimo Focused Growth & Income Fund | Other | 2.50% | 1,072,491 | 0 | 1,072,491 |
| Philotimo Fund, LP | Partnership | 1.80% | 786,453 | 0 | 786,453 |
Disclosure Items (4)
Common Shares, without Par Value
Quipt Home Medical Corp.
1019 TOWN DRIVE, WILDER, KY, 41076
Item 3 is hereby amended and restated to read as follows: The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM on behalf of the Managed Accounts were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 786,453 Shares beneficially owned by Philotimo is approximately $2,279,187 including brokerage commissions. The aggregate purchase price of the 1,072,491 Shares beneficially owned by PHLOX is approximately $2,845,939, including brokerage commissions. The aggregate purchase price of the 69,281 Shares held in the Managed Accounts is approximately $205,001, including brokerage commissions. The aggregate purchase price of the 2,302 Shares beneficially owned by Mr. Kanen is approximately $6,813, including brokerage commissions.
Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 43,443,972 Shares outstanding as of May 9, 2025 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on May 12, 2025. A. Philotimo As of the close of business on May 27, 2025, Philotimo beneficially owned 786,453 Shares. Percentage: Approximately 1.8% B. PHLOX As of the close of business on May 27, 2025, PHLOX beneficially owned 1,072,491 Shares. Percentage: Approximately 2.5% C. KWM As of the close of business on May 27, 2025, KWM beneficially owned 1,928,225 Shares, consisting of (a) the 786,453 Shares owned directly by Philotimo, which KWM may be deemed to beneficially own as the general partner of Philotimo, (b) the 1,072,491 Shares owned directly by PHLOX, which KWM may be deemed to beneficially own as the investment manager of PHLOX and (c) the 69,281 Shares held in the Managed Accounts, which KWM may be deemed to beneficially own as the investment manager of the Managed Accounts. Percentage: Approximately 4.4% D. Mr. Kanen As of the close of business on May 27, 2025, Mr. Kanen beneficially owned 1,930,527 Shares, consisting of (a) the 2,302 Shares owned directly by Mr. Kanen, (b) the 786,453 Shares owned directly by Philotimo, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, (c) the 1,072,491 Shares owned directly by PHLOX, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM, and (d) the 69,281 Shares held in the Managed Accounts, which Mr. Kanen may be deemed to beneficially own as the managing member of KWM. Percentage: Approximately 4.4%. Each Reporting Person is a member of a "group" with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and such group may be deemed to beneficially own the 1,930,527 Shares beneficially owned in the aggregate by all the Reporting Persons, constituting approximately 4.4% of the outstanding Shares. Each Reporting Person disclaims beneficial ownership of the Shares that he or it does not directly own.
Item 5(b) is hereby amended and restated to read as follows: A. Philotimo 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 786,453 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 786,453 B. PHLOX 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 1,072,491 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 1,072,491 C. KWM 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 1,928,225 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 1,928,225 D. Mr. Kanen 1. Sole power to vote or direct vote: 2,302 2. Shared power to vote or direct vote: 1,928,225 3. Sole power to dispose or direct the disposition: 2,302 4. Shared power to dispose or direct the disposition: 1,928,225
Item 5(c) is hereby amended and restated to read as follows: A. Philotimo The transactions in the Shares by Philotimo during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference. All of such transactions were effected in the open market. B. PHLOX The transactions in the Shares by PHLOX during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference. All of such transactions were effected in the open market. C. KWM The transactions in the Shares by KWM through the Managed Accounts during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference. All of such transactions were effected in the open market. D. Mr. Kanen The transactions in the Shares by Mr. Kanen during the past sixty days are set forth in Exhibit 1 and are incorporated herein by reference. All of such transactions were effected in the open market.
Item 5(e) is hereby amended and restated to read as follows: The Reporting Persons ceased to be the beneficial owners of more than 5% of the Shares of the Issuer as of May 20, 2025.
1 - Transactions in Securities.